| View |
|
DRP-11848-03
|
Sitagliptin (as phosphate monohydrate) + Metformin Hydrochloride
|
Zitamet
|
50 mg/ 500 mg
|
Film-Coated Tablet
|
Combination of Oral Blood Glucose Lowering Drugs
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
25 October 2022
|
10 May 2027
|
| View |
|
DRP-12457-01
|
Ceftriaxone (as Sodium)
|
Gentrix
|
1 g
|
Powder for Injection (I.M./I.V)
|
Antibacterial (Third Generation Cephalosorin)
|
NCPC Hebei Huamin Pharmaceutical Company Limited
|
China
|
CLIDP Conversion
|
25 October 2022
|
16 August 2027
|
| View |
|
DRP-605-20
|
Folic Acid
|
Curafol
|
5 mg
|
Capsule
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
24 October 2022
|
06 July 2026
|
| View |
|
DRP-2296-05
|
Ketorolac Trometamol
|
Aeketo
|
30 mg/mL
|
Sterile Solution for Injection (IM/IV)
|
-
|
Akums Drugs & Pharmaceuticals Ltd.
|
India
|
CLIDP Conversion
|
24 October 2022
|
01 July 2025
|
| View |
|
DRP-3109-10
|
Atorvastatin (as Calcium)
|
Gitor-40
|
40 mg
|
Film-Coated Tablet
|
Lipid Modifying Agent (HMG CoA Reductase Inhibitor)
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
29 March 2024
|
12 July 2029
|
| View |
|
DRP-9789
|
Miconazole Nitrate
|
Millis
|
20 mg/g (2.00% w/w)
|
Cream
|
-
|
S Kant Healthcare Limited
|
India
|
Initial [OTC][PCPR]
|
01 June 2021
|
01 June 2026
|
| View |
|
DRP-11574
|
Cefuroxime (as sodium)
|
Seafurox 750
|
750 mg
|
Powder For Injection (I.M./I.V.)
|
Secon Generation Cephalosporin
|
Yeluri Formulations Pvt. Ltd.
|
India
|
Initial
|
30 March 2022
|
30 March 2027
|
| View |
|
DRP-6051-16
|
Ketoanalogues + Essential Amino Acids
|
Aminolog
|
Formulation: Each film-coated tablet contains: Calcium-4-methyl-2-Oxo-valerate (a-ketoanalogue to leucine, calcium salt) Calcium-3-methyl-2-oxo-butyrate (a-ketoanalogue to valine, calcium salt) Calcium-2-oxo-3-phenylpropionate (a-ketoanalogue to phenylalanine, calcium salt) Calcium-3-methyl-2-oxo-valerate (a-ketoanalogue to isoleucine, calcium salt) Calcium-DL-2-hydroxy-4-(methylthio) butyrate (a-ketoanalogue to methionine, calcium salt)
101 mg L-Lysine Acetate
86 mg L-Threonine 68 mg L-Histidine 67 mg L-Tyrosine 59 mg L-Tryptophan
105 mg 53 mg 38 mg
30 mg
23 mg
|
Film-Coated Tablet
|
Renal Nutrition Therapy
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
12 July 2024
|
13 March 2030
|
| View |
|
DRP-3387-02
|
Cefepime hydrochloride
|
Gofime
|
2 g
|
Powder for Injection (I.M./I.V)
|
Antibacterial (Cephalosporin)
|
Yeluri Formulation Pvt. Ltd.
|
India
|
Renewal
|
24 October 2022
|
09 August 2028
|
| View |
|
DRP-3995-29
|
Cefuroxime (as Sodium)
|
Zefcure-750
|
750 mg
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
Schreechem Pharmaceuticals Pvt., Ltd.
|
India
|
CLIDP Conversion
|
24 October 2022
|
28 September 2027
|
| View |
|
DRP-4070-13
|
Fenofibrate
|
Fennotol
|
200 mg
|
Capsule
|
-
|
XL Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
24 October 2022
|
19 October 2027
|
| View |
|
DRP-4948-13
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Blu-Tazo
|
4 g/500 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Penicillin)
|
Inject Care Parenterals Pvt. Ltd
|
India
|
Renewal
|
18 April 2023
|
22 November 2028
|
| View |
|
DRP-5052-22
|
Cefixime (as trihydrate)
|
Truquest
|
100 mg/5 mL
|
Granules for Suspension
|
-
|
J.M. Tolmann Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
24 October 2022
|
18 August 2027
|
| View |
DRP-5251-02_PI_01.pdf
|
DRP-5251-02
|
Amoxicillin (as Trihydrate)
|
Welmox
|
125 mg/5 mL
|
Powder for Suspension
|
-
|
Drugmaker's Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
24 October 2022
|
28 February 2027
|
| View |
DRP-5436-02_PI_01.pdf
|
DRP-5436-02
|
Cloxacillin (as Sodium)
|
Oxcil
|
125 mg/5 mL
|
Powder for Suspension
|
-
|
Drugmaker's Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
24 October 2022
|
26 August 2027
|
| View |
DRP-5680-02_PI_01.pdf
|
DRP-5680-02
|
Allopurinol
|
Alorex
|
100 mg
|
Tablet
|
Anti-Gout
|
Drugmaker's Laboratories, Inc
|
Philippines
|
Renewal
|
15 June 2023
|
28 December 2028
|
| View |
DRP-5681-02_PI_01.pdf
|
DRP-5681-02
|
Clindamycin (as Hydrochloride)
|
Strepcin
|
150 mg
|
Capsule
|
Antibacterial (Lincosamide)
|
Drugmaker's Laboratories, Inc
|
Philippines
|
Renewal
|
19 May 2023
|
03 May 2028
|
| View |
DRP-5779-02_PI_01.pdf
|
DRP-5779-02
|
Prednisone
|
Predixone
|
5 mg
|
Tablet
|
-
|
Drugmaker's Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
24 October 2022
|
25 February 2025
|
| View |
|
DRP-6027-04
|
Omeprazole
|
Omeprex
|
40 mg
|
Delayed-Release Capsule
|
-
|
Medisure Laboratories Pakistan (Pvt.) Limited
|
Pakistan
|
CLIDP Conversion
|
24 October 2022
|
27 February 2025
|
| View |
|
DRP-6519-02
|
Montelukast (as sodium) + Levocetirizine (as dihydrochloride)
|
Telvost
|
10 mg/5 mg
|
Tablet
|
-
|
XL Laboratories Pvt. Ltd
|
India
|
CLIDP Conversion
|
24 October 2022
|
18 April 2026
|